The dose threshold for nanoparticle tumour delivery. Ouyang, B., Poon, W., Zhang, Y., Lin, Z. P., Kingston, B. R., Tavares, A. J., Zhang, Y., Chen, J., Valic, M. S., Syed, A. M., MacMillan, P., Couture-Senécal, J., Zheng, G., & Chan, W. C. W. Nat. Mater., 19(12):1362–1371, December, 2020. Bandiera_abtest: a Cg_type: Nature Research Journals Number: 12 Primary_atype: Research Publisher: Nature Publishing Group Subject_term: Cancer therapy;Nanoparticles Subject_term_id: cancer-therapy;nanoparticles
The dose threshold for nanoparticle tumour delivery [link]Paper  The dose threshold for nanoparticle tumour delivery [pdf]Paper  doi  abstract   bibtex   17 downloads  
Nanoparticle delivery to solid tumours over the past ten years has stagnated at a median of 0.7% of the injected dose. Varying nanoparticle designs and strategies have yielded only minor improvements. Here we discovered a dose threshold for improving nanoparticle tumour delivery: 1 trillion nanoparticles in mice. Doses above this threshold overwhelmed Kupffer cell uptake rates, nonlinearly decreased liver clearance, prolonged circulation and increased nanoparticle tumour delivery. This enabled up to 12% tumour delivery efficiency and delivery to 93% of cells in tumours, and also improved the therapeutic efficacy of Caelyx/Doxil. This threshold was robust across different nanoparticle types, tumour models and studies across ten years of the literature. Our results have implications for human translation and highlight a simple, but powerful, principle for designing nanoparticle cancer treatments.

Downloads: 17